It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 2020.
2020 | Chandigarh, Chandigarh, India | ActiveDamaira Pharmaceuticals Private Limited, a active private limited company, was established on 29 July 2020 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230CH2020PTC043119. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹7.00 Cr.
It upholds a compliant status. Employing 64 professional, Its leadership includes Ashish Sharma (Additional Director), Manik Bansal (Director), Vikul Bansal (Managing Director). Past directors included Vikul Bansal, Bhagwat Bansal. It holds ₹46.90 Cr open charges and ₹18.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 321-322 Sector-35 B, Chandigarh, Chandigarh, 160022.
U24230CH2020PTC043119
043119
29 July 2020
₹7.00 Cr
₹7.00 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Damaira Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Sharma | Additional Director | 13 Nov 2023 | Current |
| Manik Bansal | Director | 08 Dec 2022 | Current |
| Vikul Bansal | Managing Director | 29 Jul 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Mar 2023 | Past |
| Pramod Abcsdd | Director | 07 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Damaira Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 50043.16% increase. The company also saw a substantial improvement in profitability, with a 45.22% increase in profit. The company's net worth observed a substantial decline by a decrease of 121.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Damaira Pharmaceuticals had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹469,000,000.00
₹185,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 2024 | Hdfc Bank Limited | ₹12.00 Cr | Open |
| 26 Dec 2022 | Others | ₹34.90 Cr | Open |
| 13 Dec 2021 | Others | ₹18.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Damaira Pharmaceuticals has a workforce of 64 employees as of Mar 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Damaira Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Damaira Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 12.00 Cr with Charge ID 101032856 was registered on 23 Dec 2024. was documented.
Progress on A charge with Others of Rs. 34.90 Cr registered on 26 Dec 2022 with Charge ID 100684217 was modified on 26 Oct 2024. was documented.
The activity Damaira Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Damaira Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
Progress on Ashish Sharma was appointed as a Additional Director was appointed as a Additional Director on 13 Nov 2023 & has been associated with this company since 2 years 18 days . was documented.
A charge with Others amounted to Rs. 34.90 Cr with Charge ID 100684217 was registered on 26 Dec 2022. was recorded as a recent event.
The CIN of Damaira Pharmaceuticals Private Limited is U24230CH2020PTC043119.
Damaira Pharmaceuticals Private Limited is headquartered at Sco 321-322 Sector-35 B, Chandigarh, Chandigarh, 160022.
Damaira Pharmaceuticals Private Limited was incorporated on 29 July 2020.
The current directors of Damaira Pharmaceuticals Private Limited are
The primary industry of Damaira Pharmaceuticals Private Limited is Trade.
Damaira Pharmaceuticals Private Limited is unlisted.
The authorized capital of Damaira Pharmaceuticals Private Limited is ₹7.00 Cr, and the paid-up capital is ₹7.00 Cr.
The compliance status of Damaira Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX